Skip to content

Clinical trials

Phase 1 Lipid Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Phase: Phase 1 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20131
20142
20152
20162
20171
20181
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
CRISPR Therapeutics AG1
Indonesia University1
Luye Pharma Group Ltd.1
The Miriam Hospital1
University of Alberta1
University of Guelph1
University of Pennsylvania1
University of Texas Southwestern Medical Center1
Zydus Lifesciences Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders14
Metabolic Diseases7
Dyslipidemias5
Hyperlipidemias5
Hypercholesterolemia4
Hypertriglyceridemia3
Obesity3
Cardiovascular Diseases2
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.